Logo

ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 401k Plan overview

Plan NameENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN
Plan identification number 001

ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN Benefits

401k Plan TypeDefined Contribution Pension
Plan Features/Benefits
  • Profit-sharing
  • ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
  • Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
  • Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
  • Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
  • Participant-directed brokerage accounts provided as an investment option under the plan.
  • Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
  • Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
  • Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
  • Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

ENDO HEALTH SOLUTIONS INC. has sponsored the creation of one or more 401k plans.

Company Name:ENDO HEALTH SOLUTIONS INC.
Employer identification number (EIN):522035829
NAIC Classification:541700

Additional information about ENDO HEALTH SOLUTIONS INC.

Jurisdiction of Incorporation: State of Delaware Division of Corporations
Incorporation Date:
Company Identification Number: 2726665

More information about ENDO HEALTH SOLUTIONS INC.

Form 5500 Filing Information

Submission information for form 5500 for 401k plan ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator SignedName of Company SponsorDate Sponsor Signed
0012022-01-01
0012021-01-01
0012020-01-01
0012019-01-01
0012018-01-01
0012017-01-01VITO ROMANO CARRIE NICHOL2018-09-17
0012016-01-01VITO ROMANO DANIEL RUDIO2017-10-09
0012015-01-01VITO ROMANO DANIEL RUDIO2016-10-12
0012014-01-01VITO ROMANO DANIEL RUDIO2015-09-29
0012013-01-01VITO ROMANO DANIEL RUDIO2014-10-13
0012012-01-01VITO ROMANO DANIEL RUDIO2013-10-14
0012011-01-01ROSE MARIE GALLAGHER DANIEL A. RUDIO2012-10-15
0012009-01-01KATHY CARPENTER KEVIN MCCAUGHAN2010-10-14

Plan Statistics for ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN

401k plan membership statisitcs for ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN

Measure Date Value
2022: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2022 401k membership
Total participants, beginning-of-year2022-01-013,881
Total number of active participants reported on line 7a of the Form 55002022-01-011,335
Number of retired or separated participants receiving benefits2022-01-010
Number of other retired or separated participants entitled to future benefits2022-01-012,198
Total of all active and inactive participants2022-01-013,533
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2022-01-0127
Total participants2022-01-013,560
Number of participants with account balances2022-01-013,521
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2022-01-01115
2021: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2021 401k membership
Total participants, beginning-of-year2021-01-013,978
Total number of active participants reported on line 7a of the Form 55002021-01-011,465
Number of retired or separated participants receiving benefits2021-01-010
Number of other retired or separated participants entitled to future benefits2021-01-012,386
Total of all active and inactive participants2021-01-013,851
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2021-01-0130
Total participants2021-01-013,881
Number of participants with account balances2021-01-013,836
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2021-01-0185
2020: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2020 401k membership
Total participants, beginning-of-year2020-01-014,108
Total number of active participants reported on line 7a of the Form 55002020-01-011,912
Number of retired or separated participants receiving benefits2020-01-010
Number of other retired or separated participants entitled to future benefits2020-01-012,039
Total of all active and inactive participants2020-01-013,951
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2020-01-0127
Total participants2020-01-013,978
Number of participants with account balances2020-01-013,939
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2020-01-0159
2019: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2019 401k membership
Total participants, beginning-of-year2019-01-014,261
Total number of active participants reported on line 7a of the Form 55002019-01-011,962
Number of retired or separated participants receiving benefits2019-01-010
Number of other retired or separated participants entitled to future benefits2019-01-012,124
Total of all active and inactive participants2019-01-014,086
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2019-01-0122
Total participants2019-01-014,108
Number of participants with account balances2019-01-014,070
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2019-01-0163
2018: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2018 401k membership
Total participants, beginning-of-year2018-01-016,526
Total number of active participants reported on line 7a of the Form 55002018-01-011,918
Number of retired or separated participants receiving benefits2018-01-010
Number of other retired or separated participants entitled to future benefits2018-01-012,321
Total of all active and inactive participants2018-01-014,239
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2018-01-0122
Total participants2018-01-014,261
Number of participants with account balances2018-01-014,214
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2018-01-0130
2017: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2017 401k membership
Total participants, beginning-of-year2017-01-014,117
Total number of active participants reported on line 7a of the Form 55002017-01-012,626
Number of retired or separated participants receiving benefits2017-01-010
Number of other retired or separated participants entitled to future benefits2017-01-013,867
Total of all active and inactive participants2017-01-016,493
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2017-01-0133
Total participants2017-01-016,526
Number of participants with account balances2017-01-016,454
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2017-01-0156
2016: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2016 401k membership
Total participants, beginning-of-year2016-01-014,748
Total number of active participants reported on line 7a of the Form 55002016-01-012,231
Number of retired or separated participants receiving benefits2016-01-010
Number of other retired or separated participants entitled to future benefits2016-01-011,872
Total of all active and inactive participants2016-01-014,103
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2016-01-0114
Total participants2016-01-014,117
Number of participants with account balances2016-01-014,034
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2016-01-015
2015: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2015 401k membership
Total participants, beginning-of-year2015-01-015,169
Total number of active participants reported on line 7a of the Form 55002015-01-012,781
Number of retired or separated participants receiving benefits2015-01-010
Number of other retired or separated participants entitled to future benefits2015-01-011,959
Total of all active and inactive participants2015-01-014,740
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2015-01-018
Total participants2015-01-014,748
Number of participants with account balances2015-01-014,649
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2015-01-0116
2014: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2014 401k membership
Total participants, beginning-of-year2014-01-015,055
Total number of active participants reported on line 7a of the Form 55002014-01-013,128
Number of retired or separated participants receiving benefits2014-01-010
Number of other retired or separated participants entitled to future benefits2014-01-012,033
Total of all active and inactive participants2014-01-015,161
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2014-01-018
Total participants2014-01-015,169
Number of participants with account balances2014-01-015,083
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2014-01-017
2013: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2013 401k membership
Total participants, beginning-of-year2013-01-015,029
Total number of active participants reported on line 7a of the Form 55002013-01-013,667
Number of retired or separated participants receiving benefits2013-01-010
Number of other retired or separated participants entitled to future benefits2013-01-011,383
Total of all active and inactive participants2013-01-015,050
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2013-01-015
Total participants2013-01-015,055
Number of participants with account balances2013-01-014,886
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2013-01-011
2012: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2012 401k membership
Total participants, beginning-of-year2012-01-012,247
Total number of active participants reported on line 7a of the Form 55002012-01-014,316
Number of retired or separated participants receiving benefits2012-01-010
Number of other retired or separated participants entitled to future benefits2012-01-01711
Total of all active and inactive participants2012-01-015,027
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2012-01-012
Total participants2012-01-015,029
Number of participants with account balances2012-01-013,907
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2012-01-012
2011: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2011 401k membership
Total participants, beginning-of-year2011-01-011,610
Total number of active participants reported on line 7a of the Form 55002011-01-011,790
Number of retired or separated participants receiving benefits2011-01-010
Number of other retired or separated participants entitled to future benefits2011-01-01456
Total of all active and inactive participants2011-01-012,246
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2011-01-011
Total participants2011-01-012,247
Number of participants with account balances2011-01-012,192
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2011-01-0128
2009: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2009 401k membership
Total participants, beginning-of-year2009-01-011,586
Total number of active participants reported on line 7a of the Form 55002009-01-011,492
Number of retired or separated participants receiving benefits2009-01-010
Number of other retired or separated participants entitled to future benefits2009-01-01467
Total of all active and inactive participants2009-01-011,959
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2009-01-011
Total participants2009-01-011,960
Number of participants with account balances2009-01-011,691
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2009-01-0113

Financial Data on ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN

Measure Date Value
2022 : ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2022 401k financial data
Total unrealized appreciation/depreciation of assets2022-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$0
Total income from all sources (including contributions)2022-12-31$-70,650,057
Total loss/gain on sale of assets2022-12-31$0
Total of all expenses incurred2022-12-31$60,910,967
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2022-12-31$60,590,402
Value of total corrective distributions2022-12-31$4,531
Total contributions o plan (from employers,participants, others, non cash contrinutions)2022-12-31$25,561,795
Value of total assets at end of year2022-12-31$433,837,077
Value of total assets at beginning of year2022-12-31$565,398,101
Total of administrative expenses incurred including professional, contract, advisory and management fees2022-12-31$316,034
Total interest from all sources2022-12-31$215,392
Total dividends received (eg from common stock, registered investment company shares)2022-12-31$18,527,343
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2022-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2022-12-31$18,527,343
Administrative expenses professional fees incurred2022-12-31$11,189
Was this plan covered by a fidelity bond2022-12-31Yes
Value of fidelity bond cover2022-12-31$10,000,000
If this is an individual account plan, was there a blackout period2022-12-31No
Were there any nonexempt tranactions with any party-in-interest2022-12-31No
Contributions received from participants2022-12-31$16,662,853
Participant contributions at end of year2022-12-31$2,171,821
Participant contributions at beginning of year2022-12-31$2,935,715
Assets. Other investments not covered elsewhere at end of year2022-12-31$1,900,761
Assets. Other investments not covered elsewhere at beginning of year2022-12-31$2,280,852
Income. Received or receivable in cash from other sources (including rollovers)2022-12-31$2,408,532
Other income not declared elsewhere2022-12-31$-903,593
Administrative expenses (other) incurred2022-12-31$216,076
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Value of net income/loss2022-12-31$-131,561,024
Value of net assets at end of year (total assets less liabilities)2022-12-31$433,837,077
Value of net assets at beginning of year (total assets less liabilities)2022-12-31$565,398,101
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2022-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2022-12-31No
Were any leases to which the plan was party in default or uncollectible2022-12-31No
Investment advisory and management fees2022-12-31$88,769
Value of interest in registered invesment companies (eg mutual funds) at end of year2022-12-31$396,414,871
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2022-12-31$521,347,219
Interest on participant loans2022-12-31$99,636
Value of interest in common/collective trusts at end of year2022-12-31$26,120,127
Value of interest in common/collective trusts at beginning of year2022-12-31$33,703,328
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2022-12-31$7,229,497
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2022-12-31$5,130,987
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2022-12-31$5,130,987
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2022-12-31$115,756
Net investment gain/loss from registered investment companies (e.g. mutual funds)2022-12-31$-114,542,998
Net investment gain or loss from common/collective trusts2022-12-31$492,004
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2022-12-31No
Was there a failure to transmit to the plan any participant contributions2022-12-31No
Has the plan failed to provide any benefit when due under the plan2022-12-31No
Contributions received in cash from employer2022-12-31$6,490,410
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2022-12-31$60,590,402
Did the plan have assets held for investment2022-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2022-12-31No
Opinion of an independent qualified public accountant for this plan2022-12-31Unqualified
Accountancy firm name2022-12-31BAKER TILLY VIRCHOW KRAUSE
Accountancy firm EIN2022-12-31390859910
2021 : ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets2021-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total income from all sources (including contributions)2021-12-31$104,875,943
Total loss/gain on sale of assets2021-12-31$0
Total of all expenses incurred2021-12-31$56,545,190
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2021-12-31$56,131,543
Expenses. Certain deemed distributions of participant loans2021-12-31$50,028
Value of total corrective distributions2021-12-31$14,564
Total contributions o plan (from employers,participants, others, non cash contrinutions)2021-12-31$29,873,868
Value of total assets at end of year2021-12-31$565,398,101
Value of total assets at beginning of year2021-12-31$517,067,348
Total of administrative expenses incurred including professional, contract, advisory and management fees2021-12-31$349,055
Total interest from all sources2021-12-31$150,526
Total dividends received (eg from common stock, registered investment company shares)2021-12-31$21,197,690
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2021-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2021-12-31$21,197,690
Administrative expenses professional fees incurred2021-12-31$7,349
Was this plan covered by a fidelity bond2021-12-31Yes
Value of fidelity bond cover2021-12-31$10,000,000
If this is an individual account plan, was there a blackout period2021-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2021-12-31$0
Were there any nonexempt tranactions with any party-in-interest2021-12-31No
Contributions received from participants2021-12-31$19,763,872
Participant contributions at end of year2021-12-31$2,935,715
Participant contributions at beginning of year2021-12-31$3,198,332
Assets. Other investments not covered elsewhere at end of year2021-12-31$2,280,852
Assets. Other investments not covered elsewhere at beginning of year2021-12-31$0
Income. Received or receivable in cash from other sources (including rollovers)2021-12-31$2,554,329
Other income not declared elsewhere2021-12-31$-28,612
Administrative expenses (other) incurred2021-12-31$234,678
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Value of net income/loss2021-12-31$48,330,753
Value of net assets at end of year (total assets less liabilities)2021-12-31$565,398,101
Value of net assets at beginning of year (total assets less liabilities)2021-12-31$517,067,348
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2021-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2021-12-31No
Were any leases to which the plan was party in default or uncollectible2021-12-31No
Assets. partnership/joint venture interests at end of year2021-12-31$0
Assets. partnership/joint venture interests at beginning of year2021-12-31$0
Investment advisory and management fees2021-12-31$107,028
Value of interest in registered invesment companies (eg mutual funds) at end of year2021-12-31$521,347,219
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2021-12-31$471,600,344
Value of interest in pooled separate accounts at end of year2021-12-31$0
Value of interest in pooled separate accounts at beginning of year2021-12-31$35,018,498
Interest on participant loans2021-12-31$149,723
Value of interest in common/collective trusts at end of year2021-12-31$33,703,328
Value of interest in common/collective trusts at beginning of year2021-12-31$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2021-12-31$5,130,987
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2021-12-31$7,250,174
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2021-12-31$7,250,174
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2021-12-31$803
Net investment gain/loss from registered investment companies (e.g. mutual funds)2021-12-31$53,493,580
Net investment gain or loss from common/collective trusts2021-12-31$188,891
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2021-12-31No
Was there a failure to transmit to the plan any participant contributions2021-12-31No
Has the plan failed to provide any benefit when due under the plan2021-12-31No
Contributions received in cash from employer2021-12-31$7,555,667
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2021-12-31$56,131,543
Did the plan have assets held for investment2021-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2021-12-31No
Opinion of an independent qualified public accountant for this plan2021-12-31Unqualified
Accountancy firm name2021-12-31BAKER TILLY US, LLP
Accountancy firm EIN2021-12-31390859910
2020 : ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets2020-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Total income from all sources (including contributions)2020-12-31$102,657,589
Total loss/gain on sale of assets2020-12-31$0
Total of all expenses incurred2020-12-31$37,903,627
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2020-12-31$37,590,199
Expenses. Certain deemed distributions of participant loans2020-12-31$321
Value of total corrective distributions2020-12-31$2,409
Total contributions o plan (from employers,participants, others, non cash contrinutions)2020-12-31$28,900,878
Value of total assets at end of year2020-12-31$517,067,348
Value of total assets at beginning of year2020-12-31$452,313,386
Total of administrative expenses incurred including professional, contract, advisory and management fees2020-12-31$310,698
Total interest from all sources2020-12-31$201,016
Total dividends received (eg from common stock, registered investment company shares)2020-12-31$12,539,928
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2020-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2020-12-31$12,539,928
Administrative expenses professional fees incurred2020-12-31$10,382
Was this plan covered by a fidelity bond2020-12-31Yes
Value of fidelity bond cover2020-12-31$10,000,000
If this is an individual account plan, was there a blackout period2020-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2020-12-31$0
Were there any nonexempt tranactions with any party-in-interest2020-12-31No
Contributions received from participants2020-12-31$18,805,207
Participant contributions at end of year2020-12-31$3,198,332
Participant contributions at beginning of year2020-12-31$3,693,912
Income. Received or receivable in cash from other sources (including rollovers)2020-12-31$2,636,166
Administrative expenses (other) incurred2020-12-31$236,219
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Value of net income/loss2020-12-31$64,753,962
Value of net assets at end of year (total assets less liabilities)2020-12-31$517,067,348
Value of net assets at beginning of year (total assets less liabilities)2020-12-31$452,313,386
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2020-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2020-12-31No
Were any leases to which the plan was party in default or uncollectible2020-12-31No
Investment advisory and management fees2020-12-31$64,097
Value of interest in registered invesment companies (eg mutual funds) at end of year2020-12-31$471,600,344
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2020-12-31$416,839,145
Value of interest in pooled separate accounts at end of year2020-12-31$35,018,498
Value of interest in pooled separate accounts at beginning of year2020-12-31$31,722,329
Interest on participant loans2020-12-31$193,408
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2020-12-31$7,250,174
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2020-12-31$58,000
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2020-12-31$58,000
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2020-12-31$7,608
Net investment gain/loss from registered investment companies (e.g. mutual funds)2020-12-31$59,903,371
Net investment gain/loss from pooled separate accounts2020-12-31$1,112,396
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2020-12-31No
Was there a failure to transmit to the plan any participant contributions2020-12-31No
Has the plan failed to provide any benefit when due under the plan2020-12-31No
Contributions received in cash from employer2020-12-31$7,459,505
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2020-12-31$37,590,199
Did the plan have assets held for investment2020-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2020-12-31No
Opinion of an independent qualified public accountant for this plan2020-12-31Disclaimer
Accountancy firm name2020-12-31BAKER TILLY US, LLP
Accountancy firm EIN2020-12-31390859910
2019 : ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets2019-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total income from all sources (including contributions)2019-12-31$114,400,338
Total loss/gain on sale of assets2019-12-31$0
Total of all expenses incurred2019-12-31$43,261,993
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2019-12-31$42,822,815
Value of total corrective distributions2019-12-31$71,861
Total contributions o plan (from employers,participants, others, non cash contrinutions)2019-12-31$30,645,814
Value of total assets at end of year2019-12-31$452,313,386
Value of total assets at beginning of year2019-12-31$381,175,041
Total of administrative expenses incurred including professional, contract, advisory and management fees2019-12-31$367,317
Total interest from all sources2019-12-31$201,002
Total dividends received (eg from common stock, registered investment company shares)2019-12-31$11,766,656
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2019-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2019-12-31$11,766,656
Administrative expenses professional fees incurred2019-12-31$8,411
Was this plan covered by a fidelity bond2019-12-31Yes
Value of fidelity bond cover2019-12-31$500,000
If this is an individual account plan, was there a blackout period2019-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2019-12-31$0
Were there any nonexempt tranactions with any party-in-interest2019-12-31No
Contributions received from participants2019-12-31$18,645,267
Participant contributions at end of year2019-12-31$3,693,912
Participant contributions at beginning of year2019-12-31$3,518,674
Income. Received or receivable in cash from other sources (including rollovers)2019-12-31$4,515,613
Administrative expenses (other) incurred2019-12-31$253,908
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Value of net income/loss2019-12-31$71,138,345
Value of net assets at end of year (total assets less liabilities)2019-12-31$452,313,386
Value of net assets at beginning of year (total assets less liabilities)2019-12-31$381,175,041
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2019-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2019-12-31No
Were any leases to which the plan was party in default or uncollectible2019-12-31No
Investment advisory and management fees2019-12-31$104,998
Value of interest in registered invesment companies (eg mutual funds) at end of year2019-12-31$416,839,145
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2019-12-31$346,884,045
Value of interest in pooled separate accounts at end of year2019-12-31$31,722,329
Value of interest in pooled separate accounts at beginning of year2019-12-31$30,771,643
Interest on participant loans2019-12-31$201,000
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2019-12-31$58,000
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2019-12-31$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2019-12-31$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2019-12-31$2
Net investment gain/loss from registered investment companies (e.g. mutual funds)2019-12-31$70,707,659
Net investment gain or loss from common/collective trusts2019-12-31$1,079,207
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2019-12-31No
Was there a failure to transmit to the plan any participant contributions2019-12-31No
Has the plan failed to provide any benefit when due under the plan2019-12-31No
Contributions received in cash from employer2019-12-31$7,484,934
Employer contributions (assets) at end of year2019-12-31$0
Employer contributions (assets) at beginning of year2019-12-31$679
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2019-12-31$42,822,815
Did the plan have assets held for investment2019-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2019-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2019-12-31Yes
Opinion of an independent qualified public accountant for this plan2019-12-31Disclaimer
Accountancy firm name2019-12-31BAKER TILLY US, LLP
Accountancy firm EIN2019-12-31390859910
2018 : ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets2018-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$0
Total income from all sources (including contributions)2018-12-31$9,784,113
Total loss/gain on sale of assets2018-12-31$0
Total of all expenses incurred2018-12-31$69,976,537
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2018-12-31$69,563,964
Value of total corrective distributions2018-12-31$8,257
Total contributions o plan (from employers,participants, others, non cash contrinutions)2018-12-31$28,848,155
Value of total assets at end of year2018-12-31$381,175,041
Value of total assets at beginning of year2018-12-31$441,367,465
Total of administrative expenses incurred including professional, contract, advisory and management fees2018-12-31$404,316
Total interest from all sources2018-12-31$187,982
Total dividends received (eg from common stock, registered investment company shares)2018-12-31$12,984,431
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2018-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2018-12-31$12,984,431
Administrative expenses professional fees incurred2018-12-31$1,199
Was this plan covered by a fidelity bond2018-12-31Yes
Value of fidelity bond cover2018-12-31$10,000,000
If this is an individual account plan, was there a blackout period2018-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2018-12-31$0
Were there any nonexempt tranactions with any party-in-interest2018-12-31No
Contributions received from participants2018-12-31$17,749,858
Participant contributions at end of year2018-12-31$3,518,674
Participant contributions at beginning of year2018-12-31$4,547,803
Participant contributions at end of year2018-12-31$0
Participant contributions at beginning of year2018-12-31$0
Income. Received or receivable in cash from other sources (including rollovers)2018-12-31$3,796,417
Administrative expenses (other) incurred2018-12-31$341,509
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Value of net income/loss2018-12-31$-60,192,424
Value of net assets at end of year (total assets less liabilities)2018-12-31$381,175,041
Value of net assets at beginning of year (total assets less liabilities)2018-12-31$441,367,465
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2018-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2018-12-31No
Were any leases to which the plan was party in default or uncollectible2018-12-31No
Investment advisory and management fees2018-12-31$61,608
Value of interest in registered invesment companies (eg mutual funds) at end of year2018-12-31$346,884,045
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2018-12-31$406,491,831
Value of interest in pooled separate accounts at end of year2018-12-31$30,771,643
Value of interest in pooled separate accounts at beginning of year2018-12-31$30,327,226
Interest on participant loans2018-12-31$187,982
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2018-12-31$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2018-12-31$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2018-12-31$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)2018-12-31$-33,162,225
Net investment gain or loss from common/collective trusts2018-12-31$925,770
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2018-12-31No
Was there a failure to transmit to the plan any participant contributions2018-12-31No
Has the plan failed to provide any benefit when due under the plan2018-12-31No
Contributions received in cash from employer2018-12-31$7,301,880
Employer contributions (assets) at end of year2018-12-31$679
Employer contributions (assets) at beginning of year2018-12-31$605
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2018-12-31$69,563,964
Did the plan have assets held for investment2018-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2018-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2018-12-31Yes
Opinion of an independent qualified public accountant for this plan2018-12-31Disclaimer
Accountancy firm name2018-12-31BAKER TILLY VIRCHOW KRAUSE, LLP
Accountancy firm EIN2018-12-31390859910
2017 : ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets2017-12-31$0
Total transfer of assets to this plan2017-12-31$134,776,248
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$0
Total income from all sources (including contributions)2017-12-31$101,805,790
Total loss/gain on sale of assets2017-12-31$0
Total of all expenses incurred2017-12-31$89,480,452
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2017-12-31$88,970,417
Expenses. Certain deemed distributions of participant loans2017-12-31$63,443
Value of total corrective distributions2017-12-31$12,532
Total contributions o plan (from employers,participants, others, non cash contrinutions)2017-12-31$32,247,486
Value of total assets at end of year2017-12-31$441,367,465
Value of total assets at beginning of year2017-12-31$294,265,879
Total of administrative expenses incurred including professional, contract, advisory and management fees2017-12-31$434,060
Total interest from all sources2017-12-31$250,826
Total dividends received (eg from common stock, registered investment company shares)2017-12-31$12,607,961
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2017-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2017-12-31$12,607,961
Administrative expenses professional fees incurred2017-12-31$23,137
Was this plan covered by a fidelity bond2017-12-31Yes
Value of fidelity bond cover2017-12-31$10,000,000
If this is an individual account plan, was there a blackout period2017-12-31Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2017-12-31$0
Were there any nonexempt tranactions with any party-in-interest2017-12-31No
Contributions received from participants2017-12-31$19,804,670
Participant contributions at end of year2017-12-31$4,547,803
Participant contributions at beginning of year2017-12-31$3,590,134
Participant contributions at end of year2017-12-31$0
Participant contributions at beginning of year2017-12-31$0
Income. Received or receivable in cash from other sources (including rollovers)2017-12-31$2,020,357
Administrative expenses (other) incurred2017-12-31$326,986
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Value of net income/loss2017-12-31$12,325,338
Value of net assets at end of year (total assets less liabilities)2017-12-31$441,367,465
Value of net assets at beginning of year (total assets less liabilities)2017-12-31$294,265,879
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2017-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2017-12-31No
Were any leases to which the plan was party in default or uncollectible2017-12-31No
Investment advisory and management fees2017-12-31$83,937
Value of interest in registered invesment companies (eg mutual funds) at end of year2017-12-31$406,491,831
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2017-12-31$272,965,544
Value of interest in pooled separate accounts at end of year2017-12-31$30,327,226
Value of interest in pooled separate accounts at beginning of year2017-12-31$17,707,201
Interest on participant loans2017-12-31$249,454
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2017-12-31$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2017-12-31$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2017-12-31$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2017-12-31$1,372
Net investment gain/loss from registered investment companies (e.g. mutual funds)2017-12-31$55,805,275
Net investment gain/loss from pooled separate accounts2017-12-31$894,242
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2017-12-31No
Was there a failure to transmit to the plan any participant contributions2017-12-31No
Has the plan failed to provide any benefit when due under the plan2017-12-31No
Contributions received in cash from employer2017-12-31$10,422,459
Employer contributions (assets) at end of year2017-12-31$605
Employer contributions (assets) at beginning of year2017-12-31$3,000
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2017-12-31$88,970,417
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32017-12-31Yes
Did the plan have assets held for investment2017-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2017-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2017-12-31Yes
Opinion of an independent qualified public accountant for this plan2017-12-31Disclaimer
Accountancy firm name2017-12-31BAKER TILLY VIRCHOW KRAUSE, LLP
Accountancy firm EIN2017-12-31390859910
2016 : ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets2016-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$0
Total income from all sources (including contributions)2016-12-31$52,625,997
Total loss/gain on sale of assets2016-12-31$0
Total of all expenses incurred2016-12-31$70,506,438
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2016-12-31$70,055,505
Value of total corrective distributions2016-12-31$61,299
Total contributions o plan (from employers,participants, others, non cash contrinutions)2016-12-31$28,813,172
Value of total assets at end of year2016-12-31$294,265,879
Value of total assets at beginning of year2016-12-31$312,146,320
Total of administrative expenses incurred including professional, contract, advisory and management fees2016-12-31$389,634
Total interest from all sources2016-12-31$201,536
Total dividends received (eg from common stock, registered investment company shares)2016-12-31$11,075,393
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2016-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2016-12-31$11,075,393
Was this plan covered by a fidelity bond2016-12-31Yes
Value of fidelity bond cover2016-12-31$10,000,000
If this is an individual account plan, was there a blackout period2016-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2016-12-31$0
Were there any nonexempt tranactions with any party-in-interest2016-12-31No
Contributions received from participants2016-12-31$16,682,054
Participant contributions at end of year2016-12-31$3,590,134
Participant contributions at beginning of year2016-12-31$3,622,434
Participant contributions at end of year2016-12-31$0
Participant contributions at beginning of year2016-12-31$619
Income. Received or receivable in cash from other sources (including rollovers)2016-12-31$4,344,591
Administrative expenses (other) incurred2016-12-31$266,826
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Value of net income/loss2016-12-31$-17,880,441
Value of net assets at end of year (total assets less liabilities)2016-12-31$294,265,879
Value of net assets at beginning of year (total assets less liabilities)2016-12-31$312,146,320
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2016-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2016-12-31No
Were any leases to which the plan was party in default or uncollectible2016-12-31No
Investment advisory and management fees2016-12-31$122,808
Value of interest in registered invesment companies (eg mutual funds) at end of year2016-12-31$272,965,544
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2016-12-31$290,431,788
Value of interest in pooled separate accounts at end of year2016-12-31$17,707,201
Value of interest in pooled separate accounts at beginning of year2016-12-31$0
Interest on participant loans2016-12-31$141,056
Value of interest in common/collective trusts at end of year2016-12-31$0
Value of interest in common/collective trusts at beginning of year2016-12-31$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2016-12-31$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2016-12-31$18,091,231
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2016-12-31$18,091,231
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2016-12-31$60,480
Net investment gain/loss from registered investment companies (e.g. mutual funds)2016-12-31$12,143,491
Net investment gain/loss from pooled separate accounts2016-12-31$392,405
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2016-12-31No
Was there a failure to transmit to the plan any participant contributions2016-12-31Yes
Has the plan failed to provide any benefit when due under the plan2016-12-31No
Contributions received in cash from employer2016-12-31$7,786,527
Employer contributions (assets) at end of year2016-12-31$3,000
Employer contributions (assets) at beginning of year2016-12-31$248
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2016-12-31$70,055,505
Did the plan have assets held for investment2016-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2016-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2016-12-31Yes
Opinion of an independent qualified public accountant for this plan2016-12-31Disclaimer
Accountancy firm name2016-12-31BAKER TILLY VIRCHOW KRAUSE, LLP
Accountancy firm EIN2016-12-31390859910
2015 : ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets2015-12-31$0
Total transfer of assets to this plan2015-12-31$29,096,783
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total income from all sources (including contributions)2015-12-31$29,490,292
Total loss/gain on sale of assets2015-12-31$0
Total of all expenses incurred2015-12-31$103,539,420
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2015-12-31$103,336,087
Value of total corrective distributions2015-12-31$63,958
Total contributions o plan (from employers,participants, others, non cash contrinutions)2015-12-31$31,176,429
Value of total assets at end of year2015-12-31$312,146,320
Value of total assets at beginning of year2015-12-31$357,098,665
Total of administrative expenses incurred including professional, contract, advisory and management fees2015-12-31$139,375
Total interest from all sources2015-12-31$367,319
Total dividends received (eg from common stock, registered investment company shares)2015-12-31$15,772,708
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2015-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2015-12-31$15,772,708
Was this plan covered by a fidelity bond2015-12-31Yes
Value of fidelity bond cover2015-12-31$10,000,000
If this is an individual account plan, was there a blackout period2015-12-31Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2015-12-31$0
Were there any nonexempt tranactions with any party-in-interest2015-12-31No
Contributions received from participants2015-12-31$19,960,980
Participant contributions at end of year2015-12-31$3,622,434
Participant contributions at beginning of year2015-12-31$4,555,173
Participant contributions at end of year2015-12-31$619
Participant contributions at beginning of year2015-12-31$0
Income. Received or receivable in cash from other sources (including rollovers)2015-12-31$2,355,624
Administrative expenses (other) incurred2015-12-31$39,375
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Value of net income/loss2015-12-31$-74,049,128
Value of net assets at end of year (total assets less liabilities)2015-12-31$312,146,320
Value of net assets at beginning of year (total assets less liabilities)2015-12-31$357,098,665
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2015-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2015-12-31No
Were any leases to which the plan was party in default or uncollectible2015-12-31No
Investment advisory and management fees2015-12-31$100,000
Value of interest in registered invesment companies (eg mutual funds) at end of year2015-12-31$290,431,788
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2015-12-31$330,120,507
Interest on participant loans2015-12-31$169,763
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2015-12-31$18,091,231
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2015-12-31$22,422,985
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2015-12-31$22,422,985
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2015-12-31$197,556
Net investment gain/loss from registered investment companies (e.g. mutual funds)2015-12-31$-17,826,164
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2015-12-31No
Was there a failure to transmit to the plan any participant contributions2015-12-31Yes
Has the plan failed to provide any benefit when due under the plan2015-12-31No
Contributions received in cash from employer2015-12-31$8,859,825
Employer contributions (assets) at end of year2015-12-31$248
Employer contributions (assets) at beginning of year2015-12-31$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2015-12-31$103,336,087
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32015-12-31Yes
Did the plan have assets held for investment2015-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2015-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2015-12-31Yes
Opinion of an independent qualified public accountant for this plan2015-12-31Disclaimer
Accountancy firm name2015-12-31BAKER TILLY VIRCHOW KRAUSE, LLP
Accountancy firm EIN2015-12-31390859910
2014 : ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets2014-12-31$0
Total transfer of assets to this plan2014-12-31$0
Total transfer of assets from this plan2014-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total income from all sources (including contributions)2014-12-31$56,648,039
Total loss/gain on sale of assets2014-12-31$0
Total of all expenses incurred2014-12-31$74,670,862
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2014-12-31$74,454,430
Expenses. Certain deemed distributions of participant loans2014-12-31$84
Value of total corrective distributions2014-12-31$80,573
Total contributions o plan (from employers,participants, others, non cash contrinutions)2014-12-31$31,560,328
Value of total assets at end of year2014-12-31$357,098,665
Value of total assets at beginning of year2014-12-31$375,121,488
Total of administrative expenses incurred including professional, contract, advisory and management fees2014-12-31$135,775
Total interest from all sources2014-12-31$176,534
Total dividends received (eg from common stock, registered investment company shares)2014-12-31$18,213,381
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2014-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2014-12-31$18,213,381
Was this plan covered by a fidelity bond2014-12-31Yes
Value of fidelity bond cover2014-12-31$10,000,000
If this is an individual account plan, was there a blackout period2014-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2014-12-31$0
Were there any nonexempt tranactions with any party-in-interest2014-12-31No
Contributions received from participants2014-12-31$19,673,320
Participant contributions at end of year2014-12-31$4,555,173
Participant contributions at beginning of year2014-12-31$5,232,670
Participant contributions at end of year2014-12-31$0
Participant contributions at beginning of year2014-12-31$431
Income. Received or receivable in cash from other sources (including rollovers)2014-12-31$2,675,224
Administrative expenses (other) incurred2014-12-31$35,775
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Value of net income/loss2014-12-31$-18,022,823
Value of net assets at end of year (total assets less liabilities)2014-12-31$357,098,665
Value of net assets at beginning of year (total assets less liabilities)2014-12-31$375,121,488
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2014-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2014-12-31No
Were any leases to which the plan was party in default or uncollectible2014-12-31No
Investment advisory and management fees2014-12-31$100,000
Value of interest in registered invesment companies (eg mutual funds) at end of year2014-12-31$330,120,507
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2014-12-31$343,571,415
Interest on participant loans2014-12-31$177,600
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2014-12-31$22,422,985
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2014-12-31$26,293,822
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2014-12-31$26,293,822
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2014-12-31$-1,066
Net investment gain/loss from registered investment companies (e.g. mutual funds)2014-12-31$6,697,796
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2014-12-31No
Was there a failure to transmit to the plan any participant contributions2014-12-31Yes
Has the plan failed to provide any benefit when due under the plan2014-12-31No
Contributions received in cash from employer2014-12-31$9,211,784
Employer contributions (assets) at end of year2014-12-31$0
Employer contributions (assets) at beginning of year2014-12-31$23,150
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2014-12-31$74,454,430
Did the plan have assets held for investment2014-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2014-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2014-12-31Yes
Opinion of an independent qualified public accountant for this plan2014-12-31Disclaimer
Accountancy firm name2014-12-31BAKER TILLY VIRCHOW KRAUSE, LLP
Accountancy firm EIN2014-12-31390859910
2013 : ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets2013-12-31$0
Total transfer of assets to this plan2013-12-31$142,627,403
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total income from all sources (including contributions)2013-12-31$112,559,182
Total loss/gain on sale of assets2013-12-31$0
Total of all expenses incurred2013-12-31$80,608,054
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2013-12-31$80,420,783
Expenses. Certain deemed distributions of participant loans2013-12-31$9,454
Value of total corrective distributions2013-12-31$35,783
Total contributions o plan (from employers,participants, others, non cash contrinutions)2013-12-31$45,666,122
Value of total assets at end of year2013-12-31$375,121,488
Value of total assets at beginning of year2013-12-31$200,542,957
Total of administrative expenses incurred including professional, contract, advisory and management fees2013-12-31$142,034
Total interest from all sources2013-12-31$482,875
Total dividends received (eg from common stock, registered investment company shares)2013-12-31$15,044,949
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2013-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2013-12-31$15,044,949
Administrative expenses professional fees incurred2013-12-31$5,000
Was this plan covered by a fidelity bond2013-12-31Yes
Value of fidelity bond cover2013-12-31$10,000,000
If this is an individual account plan, was there a blackout period2013-12-31Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2013-12-31$0
Were there any nonexempt tranactions with any party-in-interest2013-12-31No
Contributions received from participants2013-12-31$25,609,513
Participant contributions at end of year2013-12-31$5,232,670
Participant contributions at beginning of year2013-12-31$3,601,067
Participant contributions at end of year2013-12-31$431
Participant contributions at beginning of year2013-12-31$383,442
Income. Received or receivable in cash from other sources (including rollovers)2013-12-31$2,512,442
Administrative expenses (other) incurred2013-12-31$48,325
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Value of net income/loss2013-12-31$31,951,128
Value of net assets at end of year (total assets less liabilities)2013-12-31$375,121,488
Value of net assets at beginning of year (total assets less liabilities)2013-12-31$200,542,957
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2013-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2013-12-31No
Were any leases to which the plan was party in default or uncollectible2013-12-31No
Investment advisory and management fees2013-12-31$88,709
Value of interest in registered invesment companies (eg mutual funds) at end of year2013-12-31$343,571,415
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2013-12-31$181,485,609
Interest on participant loans2013-12-31$208,183
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2013-12-31$26,293,822
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2013-12-31$14,985,810
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2013-12-31$14,985,810
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2013-12-31$274,692
Net investment gain/loss from registered investment companies (e.g. mutual funds)2013-12-31$51,365,236
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2013-12-31No
Was there a failure to transmit to the plan any participant contributions2013-12-31Yes
Has the plan failed to provide any benefit when due under the plan2013-12-31No
Contributions received in cash from employer2013-12-31$17,544,167
Employer contributions (assets) at end of year2013-12-31$23,150
Employer contributions (assets) at beginning of year2013-12-31$87,029
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2013-12-31$80,420,783
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32013-12-31Yes
Did the plan have assets held for investment2013-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2013-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2013-12-31Yes
Opinion of an independent qualified public accountant for this plan2013-12-31Disclaimer
Accountancy firm name2013-12-31BAKER TILLY VIRCHOW KRAUSE, LLP
Accountancy firm EIN2013-12-31390859910
2012 : ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2012 401k financial data
Total unrealized appreciation/depreciation of assets2012-12-31$0
Total transfer of assets to this plan2012-12-31$19,659,119
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total income from all sources (including contributions)2012-12-31$60,114,649
Total loss/gain on sale of assets2012-12-31$0
Total of all expenses incurred2012-12-31$21,974,396
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2012-12-31$21,843,474
Expenses. Certain deemed distributions of participant loans2012-12-31$14,113
Value of total corrective distributions2012-12-31$11,679
Total contributions o plan (from employers,participants, others, non cash contrinutions)2012-12-31$37,543,447
Value of total assets at end of year2012-12-31$200,542,957
Value of total assets at beginning of year2012-12-31$142,743,585
Total of administrative expenses incurred including professional, contract, advisory and management fees2012-12-31$105,130
Total interest from all sources2012-12-31$180,571
Total dividends received (eg from common stock, registered investment company shares)2012-12-31$4,870,155
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2012-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2012-12-31$4,870,155
Administrative expenses professional fees incurred2012-12-31$16,000
Was this plan covered by a fidelity bond2012-12-31Yes
Value of fidelity bond cover2012-12-31$10,000,000
If this is an individual account plan, was there a blackout period2012-12-31Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2012-12-31$0
Were there any nonexempt tranactions with any party-in-interest2012-12-31No
Contributions received from participants2012-12-31$20,644,920
Participant contributions at end of year2012-12-31$3,601,067
Participant contributions at beginning of year2012-12-31$2,263,673
Participant contributions at end of year2012-12-31$383,442
Participant contributions at beginning of year2012-12-31$16,623
Income. Received or receivable in cash from other sources (including rollovers)2012-12-31$3,224,774
Value of other receiveables (less allowance for doubtful accounts) at end of year2012-12-31$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2012-12-31$34,564
Administrative expenses (other) incurred2012-12-31$28,750
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Value of net income/loss2012-12-31$38,140,253
Value of net assets at end of year (total assets less liabilities)2012-12-31$200,542,957
Value of net assets at beginning of year (total assets less liabilities)2012-12-31$142,743,585
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2012-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2012-12-31No
Were any leases to which the plan was party in default or uncollectible2012-12-31No
Investment advisory and management fees2012-12-31$60,380
Value of interest in registered invesment companies (eg mutual funds) at end of year2012-12-31$181,485,609
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2012-12-31$127,003,696
Interest on participant loans2012-12-31$132,181
Value of interest in common/collective trusts at end of year2012-12-31$0
Value of interest in common/collective trusts at beginning of year2012-12-31$13,421,175
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2012-12-31$14,985,810
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2012-12-31$48,390
Net investment gain/loss from registered investment companies (e.g. mutual funds)2012-12-31$17,511,352
Net investment gain or loss from common/collective trusts2012-12-31$9,124
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2012-12-31No
Was there a failure to transmit to the plan any participant contributions2012-12-31Yes
Has the plan failed to provide any benefit when due under the plan2012-12-31No
Contributions received in cash from employer2012-12-31$13,673,753
Employer contributions (assets) at end of year2012-12-31$87,029
Employer contributions (assets) at beginning of year2012-12-31$3,854
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2012-12-31$21,843,474
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32012-12-31Yes
Did the plan have assets held for investment2012-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2012-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2012-12-31Yes
Opinion of an independent qualified public accountant for this plan2012-12-31Disclaimer
Accountancy firm name2012-12-31DELOITTE & TOUCHE LLP
Accountancy firm EIN2012-12-31133891517
2011 : ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2011 401k financial data
Total unrealized appreciation/depreciation of assets2011-12-31$0
Total transfer of assets to this plan2011-12-31$23,537,892
Total transfer of assets from this plan2011-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2011-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2011-12-31$0
Total income from all sources (including contributions)2011-12-31$22,730,028
Total loss/gain on sale of assets2011-12-31$0
Total of all expenses incurred2011-12-31$13,669,647
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2011-12-31$13,599,637
Value of total corrective distributions2011-12-31$2,046
Total contributions o plan (from employers,participants, others, non cash contrinutions)2011-12-31$25,181,688
Value of total assets at end of year2011-12-31$142,743,585
Value of total assets at beginning of year2011-12-31$110,145,312
Total of administrative expenses incurred including professional, contract, advisory and management fees2011-12-31$67,964
Total interest from all sources2011-12-31$87,142
Total dividends received (eg from common stock, registered investment company shares)2011-12-31$2,967,516
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2011-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2011-12-31$2,967,516
Was this plan covered by a fidelity bond2011-12-31Yes
Value of fidelity bond cover2011-12-31$10,000,000
If this is an individual account plan, was there a blackout period2011-12-31Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2011-12-31$0
Were there any nonexempt tranactions with any party-in-interest2011-12-31No
Contributions received from participants2011-12-31$14,148,296
Participant contributions at end of year2011-12-31$2,263,673
Participant contributions at beginning of year2011-12-31$1,549,264
Participant contributions at end of year2011-12-31$16,623
Income. Received or receivable in cash from other sources (including rollovers)2011-12-31$1,395,885
Value of other receiveables (less allowance for doubtful accounts) at end of year2011-12-31$34,564
Other income not declared elsewhere2011-12-31$0
Administrative expenses (other) incurred2011-12-31$8,650
Total non interest bearing cash at beginning of year2011-12-31$72,885,506
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Value of net income/loss2011-12-31$9,060,381
Value of net assets at end of year (total assets less liabilities)2011-12-31$142,743,585
Value of net assets at beginning of year (total assets less liabilities)2011-12-31$110,145,312
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2011-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2011-12-31No
Were any leases to which the plan was party in default or uncollectible2011-12-31No
Investment advisory and management fees2011-12-31$59,314
Value of interest in registered invesment companies (eg mutual funds) at end of year2011-12-31$127,003,696
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2011-12-31$35,710,542
Interest on participant loans2011-12-31$87,142
Value of interest in common/collective trusts at end of year2011-12-31$13,421,175
Net investment gain/loss from registered investment companies (e.g. mutual funds)2011-12-31$-6,161,168
Net investment gain or loss from common/collective trusts2011-12-31$654,850
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2011-12-31No
Was there a failure to transmit to the plan any participant contributions2011-12-31Yes
Has the plan failed to provide any benefit when due under the plan2011-12-31No
Contributions received in cash from employer2011-12-31$9,637,507
Employer contributions (assets) at end of year2011-12-31$3,854
Employer contributions (assets) at beginning of year2011-12-31$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2011-12-31$13,599,637
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32011-12-31Yes
Did the plan have assets held for investment2011-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2011-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2011-12-31Yes
Opinion of an independent qualified public accountant for this plan2011-12-31Disclaimer
Accountancy firm name2011-12-31DELOITTE & TOUCHE LLP
Accountancy firm EIN2011-12-31133891517
2010 : ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2010 401k financial data
Unrealized appreciation/depreciation of real estate assets2010-12-31$0
Unrealized appreciation/depreciation of other (non real estate) assets2010-12-31$0
Total unrealized appreciation/depreciation of assets2010-12-31$0
Total transfer of assets to this plan2010-12-31$0
Total transfer of assets from this plan2010-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2010-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2010-12-31$0
Expenses. Interest paid2010-12-31$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-1022010-12-31$0
Total income from all sources (including contributions)2010-12-31$35,055,125
Total loss/gain on sale of assets2010-12-31$0
Total of all expenses incurred2010-12-31$14,075,054
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2010-12-31$14,040,328
Expenses. Certain deemed distributions of participant loans2010-12-31$-6,500
Value of total corrective distributions2010-12-31$11,500
Total contributions o plan (from employers,participants, others, non cash contrinutions)2010-12-31$22,335,550
Value of total assets at end of year2010-12-31$110,145,312
Value of total assets at beginning of year2010-12-31$89,165,241
Total of administrative expenses incurred including professional, contract, advisory and management fees2010-12-31$29,726
Total income from rents2010-12-31$0
Total interest from all sources2010-12-31$143,055
Total dividends received (eg from common stock, registered investment company shares)2010-12-31$626,701
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2010-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2010-12-31$626,701
Administrative expenses professional fees incurred2010-12-31$0
Was this plan covered by a fidelity bond2010-12-31Yes
Value of fidelity bond cover2010-12-31$1,000,000
If this is an individual account plan, was there a blackout period2010-12-31Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2010-12-31$0
Were there any nonexempt tranactions with any party-in-interest2010-12-31No
Amount of non-exempt transactions with any party-in-interest2010-12-31$0
Contributions received from participants2010-12-31$12,748,110
Participant contributions at end of year2010-12-31$1,549,264
Participant contributions at beginning of year2010-12-31$1,391,171
Participant contributions at end of year2010-12-31$0
Participant contributions at beginning of year2010-12-31$0
Income. Received or receivable in cash from other sources (including rollovers)2010-12-31$1,403,294
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)2010-12-31$0
Value of other receiveables (less allowance for doubtful accounts) at end of year2010-12-31$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2010-12-31$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2010-12-31$0
Other income not declared elsewhere2010-12-31$28,404
Administrative expenses (other) incurred2010-12-31$193
Liabilities. Value of operating payables at beginning of year2010-12-31$0
Total non interest bearing cash at end of year2010-12-31$72,885,506
Total non interest bearing cash at beginning of year2010-12-31$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Income. Non cash contributions2010-12-31$0
Value of net income/loss2010-12-31$20,980,071
Value of net assets at end of year (total assets less liabilities)2010-12-31$110,145,312
Value of net assets at beginning of year (total assets less liabilities)2010-12-31$89,165,241
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2010-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2010-12-31No
Amount of loans by the plan or fixed income obligations due to the plan which were in default/classified-as-uncollectible as of the close of the plan year2010-12-31$0
Were any leases to which the plan was party in default or uncollectible2010-12-31No
Amount of leases to which the plan was a party which were in default/classified-as-uncollectible during the year2010-12-31$0
Investment advisory and management fees2010-12-31$0
Value of interest in registered invesment companies (eg mutual funds) at end of year2010-12-31$35,710,542
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2010-12-31$40,706,232
Value of interest in pooled separate accounts at end of year2010-12-31$0
Value of interest in pooled separate accounts at beginning of year2010-12-31$44,421,967
Interest on participant loans2010-12-31$82,141
Income. Interest from loans (other than to participants)2010-12-31$0
Interest earned on other investments2010-12-31$60,914
Income. Interest from US Government securities2010-12-31$0
Income. Interest from corporate debt instruments2010-12-31$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2010-12-31$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2010-12-31$0
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2010-12-31$2,207,978
Expenses. Payments to insurance carriers foe the provision of benefits2010-12-31$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)2010-12-31$4,550,655
Net investment gain/loss from pooled separate accounts2010-12-31$7,370,760
Net investment gain or loss from common/collective trusts2010-12-31$0
Net gain/loss from 103.12 investment entities2010-12-31$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2010-12-31No
Was there a failure to transmit to the plan any participant contributions2010-12-31Yes
Has the plan failed to provide any benefit when due under the plan2010-12-31No
Contributions received in cash from employer2010-12-31$8,184,146
Employer contributions (assets) at end of year2010-12-31$0
Employer contributions (assets) at beginning of year2010-12-31$437,893
Income. Dividends from preferred stock2010-12-31$0
Income. Dividends from common stock2010-12-31$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2010-12-31$14,040,328
Contract administrator fees2010-12-31$29,533
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32010-12-31Yes
Liabilities. Value of benefit claims payable at beginning of year2010-12-31$0
Did the plan have assets held for investment2010-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2010-12-31No
Aggregate proceeds on sale of assets2010-12-31$0
Aggregate carrying amount (costs) on sale of assets2010-12-31$0
Liabilities. Value of acquisition indebtedness at beginning of year2010-12-31$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2010-12-31Yes
Opinion of an independent qualified public accountant for this plan2010-12-31Disclaimer
Accountancy firm name2010-12-31DELOITTE & TOUCHE LLP
Accountancy firm EIN2010-12-31133891517
2009 : ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2009 401k financial data
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2009-12-31$0

Form 5500 Responses for ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN

2022: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2022 form 5500 responses
2022-01-01Type of plan entitySingle employer plan
2022-01-01Submission has been amendedNo
2022-01-01This submission is the final filingNo
2022-01-01This return/report is a short plan year return/report (less than 12 months)No
2022-01-01Plan is a collectively bargained planNo
2022-01-01Plan funding arrangement – TrustYes
2022-01-01Plan benefit arrangement - TrustYes
2021: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2021 form 5500 responses
2021-01-01Type of plan entitySingle employer plan
2021-01-01Submission has been amendedNo
2021-01-01This submission is the final filingNo
2021-01-01This return/report is a short plan year return/report (less than 12 months)No
2021-01-01Plan is a collectively bargained planNo
2021-01-01Plan funding arrangement – InsuranceYes
2021-01-01Plan funding arrangement – TrustYes
2021-01-01Plan benefit arrangement – InsuranceYes
2021-01-01Plan benefit arrangement - TrustYes
2020: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2020 form 5500 responses
2020-01-01Type of plan entitySingle employer plan
2020-01-01Submission has been amendedNo
2020-01-01This submission is the final filingNo
2020-01-01This return/report is a short plan year return/report (less than 12 months)No
2020-01-01Plan is a collectively bargained planNo
2020-01-01Plan funding arrangement – InsuranceYes
2020-01-01Plan funding arrangement – TrustYes
2020-01-01Plan benefit arrangement – InsuranceYes
2020-01-01Plan benefit arrangement - TrustYes
2019: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2019 form 5500 responses
2019-01-01Type of plan entitySingle employer plan
2019-01-01Submission has been amendedNo
2019-01-01This submission is the final filingNo
2019-01-01This return/report is a short plan year return/report (less than 12 months)No
2019-01-01Plan is a collectively bargained planNo
2019-01-01Plan funding arrangement – InsuranceYes
2019-01-01Plan funding arrangement – TrustYes
2019-01-01Plan benefit arrangement – InsuranceYes
2019-01-01Plan benefit arrangement - TrustYes
2018: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2018 form 5500 responses
2018-01-01Type of plan entitySingle employer plan
2018-01-01Submission has been amendedNo
2018-01-01This submission is the final filingNo
2018-01-01This return/report is a short plan year return/report (less than 12 months)No
2018-01-01Plan is a collectively bargained planNo
2018-01-01Plan funding arrangement – InsuranceYes
2018-01-01Plan funding arrangement – TrustYes
2018-01-01Plan benefit arrangement – InsuranceYes
2018-01-01Plan benefit arrangement - TrustYes
2017: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2017 form 5500 responses
2017-01-01Type of plan entitySingle employer plan
2017-01-01Submission has been amendedNo
2017-01-01This submission is the final filingNo
2017-01-01This return/report is a short plan year return/report (less than 12 months)No
2017-01-01Plan is a collectively bargained planNo
2017-01-01Plan funding arrangement – InsuranceYes
2017-01-01Plan funding arrangement – TrustYes
2017-01-01Plan benefit arrangement – InsuranceYes
2017-01-01Plan benefit arrangement - TrustYes
2016: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2016 form 5500 responses
2016-01-01Type of plan entitySingle employer plan
2016-01-01Submission has been amendedNo
2016-01-01This submission is the final filingNo
2016-01-01This return/report is a short plan year return/report (less than 12 months)No
2016-01-01Plan is a collectively bargained planNo
2016-01-01Plan funding arrangement – InsuranceYes
2016-01-01Plan funding arrangement – TrustYes
2016-01-01Plan benefit arrangement – InsuranceYes
2016-01-01Plan benefit arrangement - TrustYes
2015: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2015 form 5500 responses
2015-01-01Type of plan entitySingle employer plan
2015-01-01Submission has been amendedNo
2015-01-01This submission is the final filingNo
2015-01-01This return/report is a short plan year return/report (less than 12 months)No
2015-01-01Plan is a collectively bargained planNo
2015-01-01Plan funding arrangement – TrustYes
2015-01-01Plan benefit arrangement - TrustYes
2014: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2014 form 5500 responses
2014-01-01Type of plan entitySingle employer plan
2014-01-01Submission has been amendedNo
2014-01-01This submission is the final filingNo
2014-01-01This return/report is a short plan year return/report (less than 12 months)No
2014-01-01Plan is a collectively bargained planNo
2014-01-01Plan funding arrangement – TrustYes
2014-01-01Plan benefit arrangement - TrustYes
2013: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2013 form 5500 responses
2013-01-01Type of plan entitySingle employer plan
2013-01-01Submission has been amendedNo
2013-01-01This submission is the final filingNo
2013-01-01This return/report is a short plan year return/report (less than 12 months)No
2013-01-01Plan is a collectively bargained planNo
2013-01-01Plan funding arrangement – TrustYes
2013-01-01Plan benefit arrangement - TrustYes
2012: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2012 form 5500 responses
2012-01-01Type of plan entitySingle employer plan
2012-01-01Submission has been amendedNo
2012-01-01This submission is the final filingNo
2012-01-01This return/report is a short plan year return/report (less than 12 months)No
2012-01-01Plan is a collectively bargained planNo
2012-01-01Plan funding arrangement – TrustYes
2012-01-01Plan benefit arrangement - TrustYes
2011: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2011 form 5500 responses
2011-01-01Type of plan entitySingle employer plan
2011-01-01Submission has been amendedNo
2011-01-01This submission is the final filingNo
2011-01-01This return/report is a short plan year return/report (less than 12 months)No
2011-01-01Plan is a collectively bargained planNo
2011-01-01Plan funding arrangement – TrustYes
2011-01-01Plan benefit arrangement - TrustYes
2009: ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN 2009 form 5500 responses
2009-01-01Type of plan entitySingle employer plan
2009-01-01This submission is the final filingNo
2009-01-01This return/report is a short plan year return/report (less than 12 months)No
2009-01-01Plan is a collectively bargained planNo
2009-01-01Plan funding arrangement – InsuranceYes
2009-01-01Plan funding arrangement – TrustYes
2009-01-01Plan benefit arrangement – InsuranceYes
2009-01-01Plan benefit arrangement - TrustYes

Insurance Providers Used on plan

MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 65935 )
Policy contract numberSGIC 21042
Policy instance 1
Insurance contract or identification numberSGIC 21042
Number of Individuals Covered0
Insurance policy start date2021-01-01
Insurance policy end date2021-12-31
Are there contracts with allocated funds for individual policies?0
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 65935 )
Policy contract numberSGIC 21042
Policy instance 1
Insurance contract or identification numberSGIC 21042
Number of Individuals Covered685
Insurance policy start date2020-01-01
Insurance policy end date2020-12-31
Are there contracts with allocated funds for individual policies?0
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 65935 )
Policy contract numberSGIC 21042
Policy instance 1
Insurance contract or identification numberSGIC 21042
Number of Individuals Covered729
Insurance policy start date2019-01-01
Insurance policy end date2019-12-31
Are there contracts with allocated funds for individual policies?0
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 65935 )
Policy contract numberSGIC 21042
Policy instance 1
Insurance contract or identification numberSGIC 21042
Number of Individuals Covered789
Insurance policy start date2018-01-01
Insurance policy end date2018-12-31
Are there contracts with allocated funds for individual policies?0
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 65935 )
Policy contract numberSGIC 21042
Policy instance 1
Insurance contract or identification numberSGIC 21042
Number of Individuals Covered1033
Insurance policy start date2017-01-01
Insurance policy end date2017-12-31
Are there contracts with allocated funds for individual policies?0
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )
Policy contract number429974
Policy instance 1
Insurance contract or identification number429974
Number of Individuals Covered0
Insurance policy start date2010-01-01
Insurance policy end date2010-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No

Was this data useful?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Copyright © Market Footprint Ltd
Contact us   Datalog Company Directory
401k Lookup     VAT Lookup S1